|Report ID : RC-1029||Category : Healthcare||Published Date : Sep-18|
|Publisher : Report Consultant||Pages : 117||Format : PDF|
Global Direct-to-consumer Genetic Testing Market 2017-2021 About Direct-to-consumer Genetic Testing DTC genetic testing is a service that is offered by companies, retail, and clinical diagnostic laboratories directly to the consumer. DTC genetic testing services are marketed to consumers through television and print and online advertisements. DTC genetic testing is widely adopted owing to increasing awareness about gene sequencing for the early detection of diseases. However, in many countries, companies also conduct gene sequencing for matchmaking, to ascertain ancestry, and to check the vitamin level in the body.Technavio?s analysts forecast the global direct-to-consumer genetic testing market to grow at a CAGR of 11.68% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global direct-to-consumer genetic testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of DTC genetic testing services. It does not include the cost of test kits and shipping charges.The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Direct-to-consumer Genetic Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors 23andMe LabCorp Myriad Genetics Quest Diagnostics Other prominent vendors African Ancestry Alpha Biolaboratories Ambry Genetics AncestrybyDNA Anglia DNA Services Canadian DNA Services Centrillion Technology Color Genomics Counsyl Dante Labs DNA Diagnostics Center DNA Family Check DNA4Life DNA Services of America EasyDNA Full Genomes 24genetics Gene By Gene GHC GENETICS Genetic Health IDENTIGENE IntelliGenetics Invitae Living DNA Mapmygenome MyHeritage Pathway Genomics Positive Bioscience SureGenomics Shuwen Health Sciences Sonora Quest Laboratories Test Me DNA VCGS Walk-In Lab Xcode Market driver Chronic disorders in adult population For a full, detailed list, view our report Market challenge Strict guidelines by FDA and FTC in US For a full, detailed list, view our report Market trend Development of online applications to serve customer needs For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2021 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Press Releases Technavio Announces the Publication of its Research Report ? Global Direct-to-consumer Genetic Testing Market 2017-2021 Technavio recognizes the following companies as the key players in the global direct-to-consumer genetic testing market: 23andMe, LabCorp, Myriad Genetics, and Quest Diagnostics Other Prominent Vendors in the market are: African Ancestry, Alpha Biolaboratories, Ambry Genetics, AncestrybyDNA, Anglia DNA Services, Canadian DNA Services, Centrillion Technology, Color Genomics, Counsyl, Dante Labs, DNA Diagnostics Center, DNA Family Check, DNA4Life, DNA Services of America, EasyDNA, Full Genomes, 24genetics, Gene By Gene, GHC GENETICS, Genetic Health, IDENTIGENE, IntelliGenetics, Invitae, Living DNA, Mapmygenome, MyHeritage, Pathway Genomics, Positive Bioscience, SureGenomics, Shuwen Health Sciences, Sonora Quest Laboratories, Test Me DNA, VCGS, Walk-In Lab, and Xcode. Commenting on the report, an analyst from Technavio?s team said: ?The latest trend gaining momentum in the market is Development of online applications to serve customer needs. To compete with existing companies, new entrants are developing applications that can help them reach out to physicians. The growing adoption of Android has increased the adoption of applications such as KolGene, which acts as a mediator between physicians and clinical laboratories. Hence, Helix, a subsidiary of Illumina, will become a competitor for Tier 1 DTC genetic testing companies such as 23andMe and Quest Diagnostics. Illumina?s continuous focus to develop advanced next-generation sequencers and its brand recognition can increase the adoption of Helix in the future.? According to the report, one of the major drivers for this market is Chronic disorders in adult population. People between the ages of 18 to 49 are susceptible to chronic diseases such as cardiovascular diseases (CVDs) and type 2 diabetes. A study conducted by the CDC in 2016 found that in 2012, around 117 million adults were suffering from one or more chronic diseases such as heart disease or cancer. A combined study conducted by the Section of General Internal Medicine at the VA Boston Healthcare System and other institutions in 2013 on 521 adults found that respondents who had high phenotypic diabetic risk were aware of genetic testing. Further, the report states that one of the major factors hindering the growth of this market is Strict guidelines by FDA and FTC in US. To order a DTC genetic test, people need not provide information related to their medical history, pre- and post-test counseling, or other medical components. DTC genetic testing provides results with the possibility of developing gene-related diseases in the future. Hence, there is no direct connection between people and genetic counselors. Also, the Government of the US has observed that there is high adoption of DTC genetic testing in the country, which encouraged the FDA to develop strict guidelines to regulate DTC genetic testing to increase patient safety. In November 2015, the FDA sent warning letters to few companies based on tests.
Executive summary Scope of the report Research Methodology Introduction Overview DTC genetic testing Table DTC genetic testing process Market landscape Overview Table Limitations of DTC genetic testing and key focus of companies Market size and forecast Table Global DTC genetic testing market 2016-2021 ($ million) Table Adoption of DTC genetic testing and average cost of preferred tests Five forces analysis Table Five forces analysis Segmentation by service Table DTC genetic testing services: Adoption Table Global DTC genetic testing market: Segmentation by service 2016 Diagnostic screening Table Diagnostic screening using DTC genetic testing: Purpose, companies that offer services, and price Table Diagnostic screening using DTC genetic testing: Overview Table Diagnostic screening using DTC genetic testing: Market insights Prenatal, newborn screening, and preimplantation diagnosis Table Prenatal, newborn screening, and pre-implantation diagnosis using DTC genetic testing services: Overview Table Prenatal, newborn screening, and pre-implantation diagnosis: Market insights Relationship testing Table Relationship testing using DTC genetic testing services: Overview Segmentation by channel Overview Table Global DTC genetic testing market: Segmentation by distribution channel 2016 (% share) Direct sales Table DTC genetic testing through direct sales: Overview Table Direct sales: Market impact analysis Clinical laboratories Table DTC genetic testing companies and laboratories: Consumer approach Table Clinical laboratories: Regulatory paradigm analysis Retail sales Table Retail sales of paternity tests: Overview Segmentation by geography Table Global DTC genetic testing market: Segmentation by geography 2016 and 2021 ($ million) Americas Table DTC genetic testing market in Americas: Overview Table DTC genetic testing market in Americas 2016-2021 ($ million) Table DTC genetic testing market based on countries in Americas: Analysis Table DTC genetic testing in US: Overview Table Role of regulatory in genetic tests and services in US Table DTC genetic testing in US: Market dynamics EMEA Table Legislations related to DTC genetic testing in European countries Table Hospital admissions for diabetes in EMEA 2008 and 2013 (per 10,000 people) Table DTC genetic testing in EMEA: Overview Table DTC genetic testing market in EMEA 2016-2021 ($ million) Table DTC genetic testing market based on countries in EMEA: Analysis Table DTC genetic testing in UK: Overview Table DTC genetic testing in UK: Market dynamics APAC Table DTC genetic testing in APAC: Overview Table DTC genetic testing market in APAC 2016-2021 ($ million) Table DTC genetic testing market based on countries in EMEA: Analysis Decision framework Drivers and challenges Market drivers Table Growth of aging population aged 55 or more 2010-2050 (%) Table Sick leaves among people aged between 50 and 59 years in European countries due to chronic diseases 2013 (days) Table Clinical studies on DTC genetic testing awareness and market impact analysis Table Partnership models Market challenges Table Price difference in hereditary breast cancer testing Table FDA warning letters to companies Market trends Paradigm shift in business models Table Business models of DTC genetic testing companies Next-generation sequencing and biochip for present and future genetic diagnosis Development of online applications to serve customer needs Table Applications and insights Vendor landscape Competitive landscape Table Competitive structure analysis of global DTC genetic testing market 2016 Table Competitive landscape analysis of global DTC genetic testing market 2016 Table Strategic recommendations for new entrants Table Key recommendations for companies in the global DTC genetic testing market Key vendor analysis 23andMe Table 23andMe: Key highlights Table 23andMe: Strength assessment Table 23andMe: Strategy assessment Table 23andMe: Opportunity assessment LabCorp Table LabCorp: Key highlights Table LabCorp: Strength assessment Table LabCorp: Strategy assessment Table LabCorp: Opportunity assessment Myriad Genetics Table Myriad Genetics: Key highlights Table Myriad Genetics: Strength assessment Table Myriad Genetics: Strategy assessment Table Myriad Genetics: Opportunity assessment Quest Diagnostics Table Quest Diagnostics: Key highlights Table Quest Diagnostics: Strength assessment Table Quest Diagnostics: Strategy assessment Table Quest Diagnostics: Opportunity assessment Other prominent vendors Table Other prominent vendors Appendix List of abbreviations
Akasaka biz tower,
5-3-1 akasaka minato-ku,